NCT05120063

Brief Summary

In this prospective randomized four-armed study the investigators aim to compare wheter 3-D planning, which necessitates preoperative CT acquisition and sophisticated planning together with engineers, results in measurable benefits in terms of objective and subjective outcome values in a collective of patients undergoing primary total hip replacement. Hypothesis:

  1. 1.When compared to 2-D planning, 3-D planning of a THR results in better hip reconstruction, better subjective and clinical outcome and better longevity of total hip implants.
  2. 2.When compared to a non-anatomical stem, an anatomical stem allows better hip reconstruction, better subjective and clinical outcome and better longevity of total hip implants.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
133

participants targeted

Target at P50-P75 for not_applicable

Timeline
45mo left

Started Jun 2012

Longer than P75 for not_applicable

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jun 2012Jan 2030

Study Start

First participant enrolled

June 1, 2012

Completed
8.9 years until next milestone

First Submitted

Initial submission to the registry

May 6, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

November 15, 2021

Completed
8.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2030

Last Updated

August 15, 2023

Status Verified

August 1, 2023

Enrollment Period

17.7 years

First QC Date

May 6, 2021

Last Update Submit

August 14, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients, including pain, stiffness, and physical functioning of the hip. A difference in WOMAC of 2.5 points is considered relevant. 3-D-planing and/or anatomical stems will be considered superior to 2-D-planing and /or non-anatomical stems if the one year WOMAC significantly differs by 2.5.

    Change from basline to one year

  • Change in subjective hip value (SHV)

    The subjective hip value (SHV) is as a patient-reported outcome measurement (PROM) which is reported by the patient. It is easily and quickly performed and interpreted. The SHV is defined as a patient's subjective hip satisfaction expressed as a percentage of 100%, which is the score that an entirely normal hip joint would reach. A difference in subj. hip value of 25% is considered relevant. 3-D-planing and/or anatomical stems will be considered superior to 2-D-planing and /or non-anatomical stems if the one year subjective hip value significantly differs by 25%.

    Change from basline to one year

Study Arms (4)

3D anatomical stem

EXPERIMENTAL

3-D-Planing with anatomical stem (SPS monoblock stem, Symbios)

Device: SPS monoblock stem, SymbiosProcedure: 3D planning of THR

3D non-anatomical stem

EXPERIMENTAL

3-D-Planing with non anatomical stem (Quadra-H, Medacta)

Device: Quadra-H, MedactaProcedure: 3D planning of THR

2D anatomical stem

EXPERIMENTAL

2-D-Planing with anatomical stem (SPS monoblock stem, Symbios)

Device: SPS monoblock stem, SymbiosProcedure: 2D planning of THR

2D non anatomical stem

EXPERIMENTAL

2-D-Planning with non anatomical Stem (Quadra-H, Medacta)

Device: Quadra-H, MedactaProcedure: 2D planning of THR

Interventions

hip prosthesis

2D anatomical stem3D anatomical stem

hip prosthesis

2D non anatomical stem3D non-anatomical stem

primary total-hip replacement (THR) planned on 3-dimensional images (computer tomography)

3D anatomical stem3D non-anatomical stem

primary total-hip replacement (THR) planned on 2-dimensional images (anteroposteiros pelciv x-ray)

2D anatomical stem2D non anatomical stem

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients aged 40-70 years scheduled for primary THR
  • signed written informed consent.

You may not qualify if:

  • Charnley class B and C
  • ASA score \>2
  • pregnancy
  • gross hip deformity making complex hip reconstruction (greater trochanter advancement, acetabular augmentation, femoral osteotomy, use of cemented or revision stem) necessary
  • immature patients and patients incompetent to judge

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hip Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2021

First Posted

November 15, 2021

Study Start

June 1, 2012

Primary Completion (Estimated)

January 28, 2030

Study Completion (Estimated)

January 28, 2030

Last Updated

August 15, 2023

Record last verified: 2023-08